Xenon Pharmaceuticals to Present at the Stifel 2023 CNS Days

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a biopharmaceutical company focused on neurology, will present at the virtual Stifel 2023 CNS Days on March 28-29, 2023. The presentation will feature Ian Mortimer, President and CEO, and Sherry Aulin, CFO, on March 28 at 1:00 PM Eastern Time (10:00 AM Pacific Time). A live webcast will be available and can be pre-registered for via a provided link. Xenon is dedicated to developing innovative therapies for neurological disorders, particularly epilepsy. For further information, visit www.xenon-pharma.com.

BURNABY, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the virtual Stifel 2023 CNS Days taking place March 28-29, 2023.

Company Fireside Chat Presentation Details:
Date:	Tuesday, March 28, 2023
Time:	1:00 pm Eastern Time (10:00 am Pacific Time)
Presenters:	Ian Mortimer, President and CEO
	Sherry Aulin, CFO
Webcast:	Link to pre-register for the webcast can be found here.

A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

 

FAQ

When will Xenon Pharmaceuticals present at the Stifel 2023 CNS Days?

Xenon Pharmaceuticals will present on March 28, 2023.

Who will be presenting at the Stifel 2023 CNS Days?

Ian Mortimer, President and CEO, and Sherry Aulin, CFO, will be presenting.

What time is Xenon's presentation at the Stifel 2023 CNS Days?

The presentation is scheduled for 1:00 PM Eastern Time (10:00 AM Pacific Time).

Where can I watch the live webcast of Xenon's presentation?

The live webcast can be accessed via a link provided in their press release and on Xenon's website.

What is the focus of Xenon Pharmaceuticals?

Xenon Pharmaceuticals focuses on developing therapies for neurological disorders, with an emphasis on epilepsy.